Iran reports damage to 23 pharmaceutical companies following attacks
Note: AI technology was used to generate this article’s audio.
- Recent attacks damaged 23 pharmaceutical companies in Iran, including 15 manufacturers and eight distributors.
- Iran is facing difficulties securing 37 types of essential medicines out of approximately 700.
- The damage could disrupt medicine production and raw material supplies, but quality standards will remain unchanged.
Iran's Food and Drug Administration said recent attacks on the country damaged 23 pharmaceutical companies, raising concerns over medicine production and supply.
The Tasnim News Agency quoted the agency as saying that 15 pharmaceutical manufacturing companies and eight distribution companies were affected.
The agency's spokesperson said Iran is facing difficulties securing 37 types of medicines out of approximately 700 vital and essential drugs.
It warned that the damage could affect pharmaceutical production and the supply of raw materials required for manufacturing medicines.
However, the agency stressed that the disruption would not lead to any changes in quality standards or manufacturing regulations.
